Head External Innovation Technologies, Bayer AG
1st Jan 2018
London, United Kingdom
Venue to be confirmed
There have been enormous gains in health outcomes and life expectancy over the last 30 years. For this progress to continue it is likely that existing innovation platforms for drug and device discovery will play an important role. But it is undeniable that there will also be a host of new scientific platforms that will include digital tools, robotics, artificial intelligence based on machine learning and totally new therapeutic approaches to disease such as cell/gene therapy and immunotherapy to name a few. The rapid growth of ‘omics’ knowledge and technology is expected to continue and with it more life-saving applications in medical science.
In order to make the most of these innovations, strategies that effectively transfer new technologies from the “bench” will have to be developed. This is the key focus of the meeting.
Our full speaker panel can be found here
The European Life Science Innovation Conference 2018 will explore novel R&D and business innovation models and will serve as an effective networking platform, bringing together all the key stakeholders in the life science innovation ecosystem.
During the two-day conference, there will be networking breaks to promote interaction with your peers, expert led case study presentations, a dynamic exhibition room filled with technology providers showcasing their technologies and solutions, and roundtable discussions for in-depth exploration of strategies for harnessing innovation for sustainable growth and an exploration of the future of bio-innovation.
Medical innovation has vastly improved human health and significantly reduced the costs associated with healthcare. At this event, you will explore the latest significant breakthroughs in the diverse fields of immuno-oncology, neurological disorders and antimicrobial resistance.
Topics will include collaborations in drug discovery
Best of both worlds (industry/academia partnerships with examples from research on neurodegenerative disorders
Global crowdsourcing and hackathon innovation
New models of partnership linking academia
Innovation in West and East using UK and Singapore as models
Tools to protect innovation: Patents, trademarks etc.
Role of public policy and public/private partnerships in innovation